There is a question that has been in the back of my mind that comes front and center every now and then (usually after financials).
How much capital will be spent on the NAL mine and concentrator?
You get told what the acquisition cost was (~AUD$100M ... yes?)
You get told what the upgrade of mine/concentrator for NAL restart was (~AUD$110M ... yes?)
Makes PLL's equity share of ~US$50M
You get told that NAL was restarted "on time" and "on budget
You get a DFS for CAD$375M for NAL ... excluding refinery ... and sure it has LOM Capex (so reclaimation and closure) ... but it also excludes acquisition and upgrade capital spent as "sunk cost"
You get a lot of chest beating going on about PLL elsewhere, but when its all said and done I wonder how much NAL mine/conc is going to cost as compared to a greenfield ... such as say Ewoyaa (a substantially bigger operation) ... oh I forgot it's never gunna be built as Ghana Gov't is going to steal it.
- Forums
- ASX - By Stock
- PLL
- Ann: Quarterly Report (Form 10-Q)
PLL
piedmont lithium inc.
Add to My Watchlist
0.00%
!
9.8¢

Ann: Quarterly Report (Form 10-Q), page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
9.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $51.09M |
Open | High | Low | Value | Volume |
9.9¢ | 9.9¢ | 9.6¢ | $108.4K | 1.119M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 24500 | 9.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.8¢ | 68309 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 19000 | 0.096 |
2 | 210638 | 0.094 |
1 | 33000 | 0.093 |
1 | 10000 | 0.091 |
4 | 138700 | 0.090 |
Price($) | Vol. | No. |
---|---|---|
0.098 | 3000 | 1 |
0.099 | 110313 | 3 |
0.100 | 378753 | 4 |
0.105 | 531437 | 15 |
0.110 | 317649 | 10 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
PLL (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online